Patient-reported outcomes (PROs) with talazoparib (TALA) plus enzalutamide (ENZA) vs. placebo (PBO) plus ENZA in men with metastatic castration-resistant prostate cancer (mCRPC): Subgroup analysis of ...
MedPage Today on MSN
Post-ICU Rehab Program Misses Mark for Improving Quality of Life
But the remote intervention showed signals of benefit over the longer term and in subgroup ...
Integration of Telemedicine Consultation Into a Tertiary Radiation Oncology Department: Predictors of Use, Treatment Yield, and Effects on Patient Population Using the scoping review methodology ...
The impact alopecia areata (AA) has on patients' health-related quality of life (HRQOL) may not be accurately measured with EQ-5D-5L, suggesting the need for alternative assessments. The EQ-5D-5L is ...
The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how ...
As part of our commitment, we've once again partnered with Statista, Inc. to evaluate the implementation of Patient Reported Outcome Measures (PROMs) in the leading hospitals around the world.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results